Trademark: 88305684
Word
HARLAN
Status
Dead
Status Code
606
Status Date
Monday, August 21, 2023
Serial Number
88305684
Mark Type
3000
Filing Date
Monday, February 18, 2019
Published for Opposition
Tuesday, May 26, 2020
Abandoned Date
Monday, August 21, 2023

Trademark Owner History
Envigo Holding I, Inc. - Owner At Publication

Classifications
45 reviewing standards and practices to assure compliance with federal food, drug and environmental laws and regulations; reviewing standards and practices to assure compliance with environmental safety laws and regulations; preparing environmental safety compliance reports; reviewing standards and practices to assure compliance with federal agriculture laws and regulations, namely, those relating to laboratory animal science
44 laboratory animal breeding; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals, namely, holding and feeding animals special diets and/or supplements, allowing animals to develop to certain ages before supplying them to customers, performing surgical manipulations on animals and recording and measuring various phenotypic parameters; genetic testing of laboratory animals for research purposes; consulting services in the field of laboratory animal health care, namely, proper utilization of health precautions, the gaps and threats in pathogen targets in healthy panels, interpretation of test results, and the development of custom diet plans; surgery; animal breeding; animal husbandry; genetic testing of animals for diagnostic or treatment purposes; surgery on animals; medical diagnostic testing services, namely, health evaluation of animals
31 live laboratory animals; animal feed
42 clinical research services in the field of vaccines, biologics, gene therapy, and biopharmaceuticals, pharmacy, medicine, and biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding, namely, collection, calibration, and reporting of data in connection with clinical trials of pharmaceuticals and medical devices; testing and product development of biopharmaceuticals and medical devices; laboratory research in the fields of biology and chemistry, namely, genotyping and phenotyping of animals; Custom design and development of chemical reagents and biochemical assays; laboratory animal scientific research and testing in the fields of pharmacy, medicine, biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding; avian egg development and testing services for the purpose of scientific research and new product research and development; research and development of chemicals, agrochemicals, pharmaceuticals, biologics, vaccines and medical devices; scientific testing of chemicals, agrochemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, pesticides, medical devices, vaccines, and biologics; toxicological safety testing services for pharmaceuticals, chemicals, agrochemicals, and consumer products; research and scientific testing of pharmaceuticals, biopharmaceuticals, biologics, and medical devices for the presence of endotoxins; animal medical research and testing services in the field vaccines, biologics, gene therapy, and biopharmaceuticals, pharmacy, medicine, and biology and chemistry, namely, genotyping, zygosity, gene expression, antibody, custom laboratory animal diets, and breeding; avian egg development and testing services for the purpose of medical research; Consultation services in the field of providing guidance on scientific research and development for the purposes of providing medical information; laboratory services in the fields of product development and scientific and medical research; Scientific and technological services, namely, scientific testing services in the fields of product development and scientific and medical research; product development services; consulting services for others in the field of scientific and medical research of clinical trials, clinical trial management, and clinical trial recruiting; conducting clinical trials for others; toxicology services
The mark consists of the word "HARLAN" with a depiction of a molecule overlapping the letter "A".
Color is not claimed as a feature of the mark.

Trademark Events
Aug 21, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 21, 2023
Abandonment - No Use Statement Filed
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 5 Granted
Jan 20, 2023
Sou Extension 5 Filed
Feb 7, 2023
Case Assigned To Intent To Use Paralegal
Jan 20, 2023
Sou Teas Extension Received
Jul 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2022
Sou Extension 4 Granted
Jul 18, 2022
Sou Extension 4 Filed
Jul 18, 2022
Sou Teas Extension Received
Jan 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2022
Sou Extension 3 Granted
Jan 12, 2022
Sou Extension 3 Filed
Jan 12, 2022
Sou Teas Extension Received
Sep 29, 2021
Assigned To Examiner
Jul 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2021
Sou Extension 2 Granted
Jul 20, 2021
Sou Extension 2 Filed
Jul 20, 2021
Sou Teas Extension Received
Feb 10, 2021
Assignment Of Ownership Not Updated Automatically
Nov 25, 2020
Assignment Of Ownership Not Updated Automatically
Nov 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 20, 2020
Sou Extension 1 Granted
Nov 20, 2020
Sou Extension 1 Filed
Nov 20, 2020
Sou Teas Extension Received
Jul 21, 2020
Noa E-Mailed - Sou Required From Applicant
May 26, 2020
Official Gazette Publication Confirmation E-Mailed
May 26, 2020
Published For Opposition
May 6, 2020
Notification Of Notice Of Publication E-Mailed
Apr 10, 2020
Approved For Pub - Principal Register
Apr 10, 2020
Examiner's Amendment Entered
Apr 10, 2020
Notification Of Examiners Amendment E-Mailed
Apr 10, 2020
Examiners Amendment E-Mailed
Apr 10, 2020
Examiners Amendment -Written
Apr 1, 2020
Teas/Email Correspondence Entered
Apr 1, 2020
Correspondence Received In Law Office
Apr 1, 2020
Teas Request For Reconsideration Received
Nov 19, 2019
Notification Of Final Refusal Emailed
Nov 19, 2019
Final Refusal E-Mailed
Nov 19, 2019
Final Refusal Written
Nov 4, 2019
Teas/Email Correspondence Entered
Nov 4, 2019
Correspondence Received In Law Office
Nov 4, 2019
Teas Response To Office Action Received
May 4, 2019
Notification Of Non-Final Action E-Mailed
May 4, 2019
Non-Final Action E-Mailed
May 4, 2019
Non-Final Action Written
Apr 30, 2019
Assigned To Examiner
Mar 21, 2019
Notice Of Design Search Code E-Mailed
Mar 10, 2019
New Application Office Supplied Data Entered
Feb 21, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24